- Medical - Care Facilities
- Healthcare
-
3.92
EPS
-
14.74
P/E
-
9.98B
MARKET CAP
-
0.00%
DIV YIELD
Company Overview
, ,
CEO
Mr. Bryan C. Hanson
Employess
22000
Sector
Healthcare
Industry
Medical - Care Facilities
Website
https://www.solventum.com
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.
Next Earnings Date
Nov. 14, 2024
Ex Dividends date
--
Dividend Date
--
YTD Performance
-27.70%
Fiscal Year End
None
IPO Date
2024-04-01
Growth Rates
(avg. rate of change) | 10 years | 5 years | 3 years | 1 year |
---|---|---|---|---|
Sales/Revenue | % | % | 4.21% | 1.37% |
EPS | % | % | -15.30% | -48.52% |
Equity | % | % | -34.37% | -70.97% |
Cash | % | % | 87.52% | 883.61% |
Return On Capital (ROIC) | % | % | 10.81% | 9.59% |
Debt
year (millions) | 2023 | 2022 | 2021 | |
---|---|---|---|---|
Short Term Debt | 29 | 233 | 325 | |
Long Term Debt | 8,300 | 68 | 83 | |
LT Finance Leases | 69 | 68 | 112 | |
Shares Outstanding | 172 | 172 | 172 | 172 |
Market Cap | 13,800 | 13,800 | 13,800 | 13,800 |
Price
News
Solventum Corporation (SOLV) Q2 2024 Earnings Call Transcript
1 monthSolventum Corporation (NYSE:SOLV ) Q2 2024 Earnings Call August 8, 2024 4:30 PM ET Company Participants Kevin Moran - Senior Vice President, Investor Relations Bryan Hanson - Chief Executive Officer Wayde McMillan - Chief Financial Officer Conference Call Participants Travis Steed - Bank of America Vik Chopra - Wells Fargo David Roman - Goldman Sachs Operator Good day. My name is Ellie, and I will be your conference operator for today.
seekingalpha.comSolventum's second-quarter profit falls 70% on higher expenses
1 month3M spin-off Solventum's second-quarter profit fell more than 70% on Thursday, hurt by limited sales growth of its wound care and surgical sterilization products and higher expenses, as it navigates functioning as a newly independent company.
reuters.comSolventum Reports Second Quarter 2024 Financial Results and Raises Full-Year Guidance
1 monthSeparation activities and business continuity on track Reported sales increased 0.2% to $2.081 billion; organic sales increased 1.3% GAAP Earnings Per Share (EPS) of $0.51; adjusted EPS1 of $1.56 Generated $355 million in cash from operations; free cash flow1 of $297 million Raises full-year 2024 organic sales growth and adjusted EPS guidance ST. PAUL, Minn.
prnewswire.com4 Dividend Aristocrats To Buy In August And More To Watch
1 month“Dividend Aristocrats
seekingalpha.comCurreen Capital: Ugly Ducklings Selling At An Attractive Price
2 monthsWe were more active than usual in the quarter, buying shares that were available at very attractive prices. All in, we have ugly ducklings - high returns on capital, cash cow spinoffs, working through resolvable issues, and selling at attractive prices. I love buying businesses like this, and if it drops to my next buy price, we will add to it.
seekingalpha.comActivist Trian has a few levers to pull to build shareholder value at Solventum
2 monthsSince its spinoff from 3M, Solventum has been under-covered and misunderstood by the market.
cnbc.comSOLV Stock Alert: Solventum Pops as Activist Investor Trian Capital Takes Stake
2 monthsSolventum (NYSE: SOLV ) stock is up on Tuesday after activist investor Trian Capital took a stake in the healthcare company. According to insider sources, Trian Capital has taken a large stake in the company.
investorplace.comSolventum Stock Jumps as Activist Trian Discloses Stake
2 monthsThe move comes just months after 3M spun off the healthcare product company.
barrons.comNelson Peltz's Trian said to build stake in 3M spinoff Solventum, Bloomberg News reports
2 monthsActivist investor Nelson Peltz's Trian Fund Management has built a stake in 3M's healthcare spinoff Solventum , Bloomberg News reported on Monday, citing people with knowledge of the matter, sending shares of the company up 3.4% after the bell.
reuters.comSolventum to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024
2 monthsST. PAUL, Minn., July 16, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV) will release its second quarter 2024 financial results on Thursday, August 8, 2024 after the U.S. financial markets close.
prnewswire.comU.S. News & World Report Expands Use of Solventum's Ambulatory Potentially Preventable Complications Grouping Software for Use in Its 2024-2025 Best Hospitals Rankings
3 monthsST. PAUL, Minn., July 2, 2024 /PRNewswire/ -- Solventum today announced that U.S. News & World Report is expanding its use of Solventum's 3M™ Ambulatory Potentially Preventable Complications (AM-PPCs) software in the analysis of its 2024-2025 Best Hospitals rankings.
prnewswire.comSolventum introduces denials prevention solution, an AI-powered tool, empowering health systems to help reduce write-offs and improve top line revenue
3 monthsST. PAUL, Minn., June 24, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV), [formerly 3M Health Care] today announced a new artificial intelligence (AI)-driven payment integrity and revenue cycle solution, Solventum™ Revenue Integrity System.
prnewswire.com